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ABSTRACT Activity of several ion channels is controlled
by heterotrimeric GTP-binding proteins (G proteins) via a
membrane-delimited pathway that does not involve cytoplas-
mic intermediates. The best studied example is the K+ channel
activated by muscarinic agonists in the atrium, which plays a
crucial role in regulating the heartbeat. To enable studies of the
molecular mechanisms of activation, this channel, denoted
KGA, was cloned from a rat atriumcDNA library by functional
coupling to coexpressed serotonin type 1A receptors in Xenopus
oocytes. KGA displays regions of sequence homology to other
inwardiy rectifying channels as well as unique regions that may
govern G-protein interaction. The expressed KGA channel is
activated by serotonin 1A, muscarinic m2, and b-opioid recep-
tors via G proteins. KGA is activated by guanosine 5'-[y-
thio]triphosphate in excised patches, confirming activation by
a membrane-delimited pathway, and displays a conductance
equal to that of the endogenous channel in atrial cells. The
hypothesis that similar channels play a role in neuronal inhi-
bition is supported by the cloning of a nearly identical channel
(KGB1) from a rat brain cDNA library.
A major signal transduction mechanism in cardiac physiology
and neurobiology is the direct coupling of neurotransmitter
receptors to ion channels by a membrane-delimited pathway
that does not involve cytoplasmic intermediates (for reviews,
see refs. 1 and 2). The best studied member of this group is
the G protein-activated K+ channel found in atria of all
vertebrates. This channel, which we denote KGA, figured in
the original discovery of chemical synaptic transmission (3,
4) and plays a crucial role in regulating the heartbeat. The
KGA channel rectifies at the single-channel level, allowing
much larger inward than outward currents (5, 6). It is
activated by acetylcholine acting on muscarinic m2 receptors
via a pathway that includes a pertussis toxin (PTX)-sensitive
G protein, probably of the G, family (1, 7-12). In excised
membrane patches, either the activated Gi a subunit or the ,fy
subunit dimer activates the K+ channels directly (11-14). The
same or a similar K+ channel can be activated by serotonin
type 1A (5HT1A) and/or by 'y-aminobutyrate type B
(GABAB) receptors in the hippocampus via a PTX-sensitive
G protein(s) (2, 15, 16). In the brain, this channel may regulate
firing rates, membrane potential, and neurotransmitter re-
sponses. It is probable, but not certain, that these ion
channels are examples of direct gating of an ion channel by
an intracellular ligand; i.e., a G protein binds directly as a
ligand to the cytoplasmic side of the channel and induces
opening or closing. Cloning ofKGA would allow mechanisms
ofG protein-effector interaction to be studied on the level of
a single molecule by use of the powerful blend of molecular
biology and electrophysiology approaches.
The publication costs of this article were defrayed in part by page charge
payment. This article must therefore be hereby marked "advertisement"
in accordance with 18 U.S.C. §1734 solely to indicate this fact.
By low-stringency hybridization or related PCR methods,
a large number of voltage-sensitive K+ channels have been
cloned, starting with sequence data from the original Shaker
K+ channel. However, no member of the inwardly rectifying
K+ channel family has yet been cloned by this approach,
suggesting considerable sequence divergence between the
inwardly rectifying and most of the voltage-dependent K+
channels. Recently this expectation was confirmed when
cDNAs oftwo inwardly rectifying K+ channels were isolated
by expression cloning methods (17, 18). The two proteins,
ROMK1 and IRK1, are encoded by members of a separate
gene family. The prominent features of their predicted sec-
ondary structure are a pore-forming region (P) characteristic
of all voltage-dependent channels (e.g., refs. 19 and 20),
flanked by two hydrophobic membrane-spanning domains,
Ml and M2 (in contrast with the members of the voltage-
dependent K+ channel family, which contain six hydropho-
bic transmembrane domains per subunit), and cytoplasmic N
and C termini (17, 18).
However, these two channels, isolated from kidney and
macrophage cDNA libraries, respectively, are not known to
be G protein-gated and are constitutively active when ex-
pressed in Xenopus oocytes. Prior to the publication of the
results concerning ROMK1 and IRK1, we had independently
initiated a cloning project for KGA. The expression cloning
of KGA is complicated by the necessity to introduce a
seven-helix receptor that can couple to an oocyte's G protein
and activate the channel. The natural pathway for activation
ofKGA (by acetylcholine via the m2 receptor) produced only
small inward-rectifier K+ currents in oocytes injected with
atrial mRNA. Coinjection of atrial mRNA and cRNA of the
cloned 5HT1A receptor [which has been shown to be able to
couple to KGA in atrial cells (21)] gave a much larger signal
(22). We report here that this assay has been used for isolating
KGA. The sequence of KGA indicates that it is a third
member of the ROMK1/IRK1 family. A virtually identical
channel (KGB1) is present in the brain, as shown by cloning
of its cDNA by homology screening of a brain library. 11
Abbreviations: 5HT, 5-hydroxytryptamine (serotonin); PTX, per-
tussis toxin; GTP[yS], guanosine 5'-[y-thio]triphosphate.
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MATERIALS AND METHODS
Preparation ofRNAs and ofcDNA Libraries. Atrial and brain
poly(A)+ RNAs were prepared from 19-day-old rats as de-
scribed (23). Directional cDNA libraries were constructed
with the Stratagene Uni-ZAP cDNA synthesis kit, by inserting
poly(A)+-primed reverse-transcribed hemimethylated cDNA
(size-selected above 1.3 kb) into pBluescript II KS(-) between
EcoRI and Xho I sites. A portion of this cDNA was electro-
porated into Top 10 F- electrocompetent cells (Invitrogen),
yielding =3.6 x 105 clones (atrium) or =4 x 105 clones (brain).
For expression cloning, atrial cDNA was linearized for tran-
scription by an 8- to 12-cycle PCR using Deep Vent polymer-
ase (New England Biolabs) with 20- and 37-mer primers
roughly corresponding to the M13-20 and reverse primers of
pBluescript, with the addition of a (dT)20 stretch to the 5' end
of the latter. KGB1 was cloned by homology screening of the
brain library with the full-length KGA probe by standard
procedures (24). KGA and KGB1 cDNAs were sequenced by
a nested-deletion (Erase-a-Base, Promega, Madison, WI) dye-
terminator protocol (Caltech), and KGA was independently
sequenced by a transposon-based strategy (Amgen Biologi-
cals), in both cases with Applied Biosystems equipment.
Human 5HT1A receptor cDNA (46) was linearized with Not
I. cDNA of the 8-opioid receptor from NG-108-15 neuroblas-
toma-glioma cells (25) was amplified by PCR with primers
designed to add an SP6 phage promoter and 26 bp of alfalfa
mosaic virus (AMV) 5' untranslated region at the 5' end and
a (dT)20 sequence at the 3' end (see ref. 26). The human m2
receptor cDNA (27) was linearized with HindIII. After KGA
cDNA was isolated, it was routinely linearized withXho I. All
RNAs were transcribed in vitro with the corresponding RNA
polymerases (23).
Northern blot hybridizations were performed with a digox-
ygenin-labeled (Boehringer Mannheim) full-length KGA
cDNA probe (atrial RNA) or with a KGA cDNA probe
lacking the 3' untranslated region (RNA from other tissues).
Membranes were hybridized overnight [atrial samples at 41°C
in 50% formamide/5x standard saline citrate (SSC)/0.02%
SDS/0.1% sodium lauryl sarcosinate/20 mM sodium male-
ate; other tissues at 65°C in 5x SSC/0.1% sodium lauryl
sarcosinate/0.02% SDS] and washed at intermediate strin-
gency (65°C; 0.5x SSC/0.1% SDS).
cDNA Sequence Analysis. Database screening utilized the
FASTA program, and sequence alignment of KGA/IRK1/
ROMK1 the PILEUP program, of the Genetics Computer
Group package (28). Amino acid similarity was calculated
using the GCG default peptide symbol comparison table (29).
Hydrophobicity analysis (11-amino acid window; see ref. 30)
and transmembrane helix prediction (31) were performed
with the PCGENE package (IntelliGenetics).
Oocyte Culture and Electrophysiology. Xenopus oocytes
were prepared and injected (23) with the following cRNAs:
pools derived from the library, 10-100 ng; KGA, 1-2 ng;
KGB1, 1-10 ng; 5HT1A receptor, 5-30 ng; m2 receptor,
0.1-1 ng; 6-opioid receptor, 0.1-1 ng. The oocytes were
incubated 3-5 days at 22°C in ND96 solution (96mM NaCl/2
mM KCl/1 mM CaCl2/1 mM MgCl2/5 mM Hepes, pH 7.6)
supplemented with gentamicin (50 ,ig/ml), 2.5 mM sodium
pyruvate, and, occasionally, 0.5 mM theophylline.
Two-electrode voltage clamp was performed with a Dagan
8500 (Dagan Instruments, Minneapolis) amplifier as de-
scribed (32). The oocyte was placed in a chamber perfused
with ND96 (pH 7.4-7.5), the holding potential was set at -80
mV, and the solution was changed to hK (96 mM KCI/2 mM
NaCl/l mM CaCl2/1 mM MgC92/5 mM Hepes, pH 7.4-7.5).
Intermediate concentrations of K+ were obtained by mixing
ND96 and hK solutions. Current-voltage (I-V) characteris-
tics were recorded by using voltage ramps (between -120 or
-80 mV and +40 mV) lasting 1 s.
Single-channel recordings (33) were made with an Axo-
patch 1D amplifier (Axon Instruments, Burlingame, CA) with
a capacitive headstage using PCLAMP software (Axon Instru-
ments). Atrial cells were prepared from 9- to 10-week-old rats
essentially as described (34). Borosilicate glass pipettes were
filed with a 150 mM K+ solution (140 mM KCl/l mM
MgCl2/1 mM CaCl2/2 mM NaCl/10 mM Hepes/KOH, pH
7.5). In some cases, to inhibit the activity of the stretch-
activated channels in oocyte patches, 100 ALM GdCl3 was
added to the pipette solution. The bath solution contained 150
mM KCl, 1 mM EGTA, 1-4 mM MgCl2, 10 mM Hepes/NaOH
(pH 7.5); 5 mM ATP was added to inhibit the activity of
ATP-dependent K+ channels in atrial patches. The continu-
ous records were acquired with a chart recorder (e.g., Fig.
3C) or with a video cassette recorder (e.g., Fig. 3D).
RESULTS AND DISCUSSION
5HT-evoked inward K+ currents were measured in the
high-K+ solution (hK) by using the two-electrode voltage
clamp. Small ('4 nA) responses were evoked by 5HT in
oocytes coinjected with SHT1A receptor RNA and cRNA
transcribed in vitro from cDNA from an atrial library pool of
~-40,000 colonies. Sequential subdivisions of the pool led to
appropriately larger responses and, eventually, to identifica-
tion ofa single 2070-base-pair (bp) cDNA containing a 1503-bp
(bases 32-1534) open reading frame encoding KGA, a 501
amino acid protein of predicted molecular mass 56,573 Da
(Fig. 1A). Screening of the GenBank database revealed ho-
mology between KGA and only two other proteins, IRK1 (18)
and ROMK1 (17) (47% and 40% sequence identity, 66% and
65% similarity, respectively) (Fig. 1A). The predicted second-
ary structure ofKGA, like that ofIRK1 and ROMK1, includes
a pore-forming region (P) flanked by two hydrophobic mem-
brane-spanning domains, Ml and M2 (Fig. 2B), and cytoplas-
mic N and C termini. The pore-forming region displays high
homology to that of IRK1 and ROMK1 (72% and 67% iden-
tity), but less than that between IRK1 and ROMK1 themselves
(89%o). The absence of a signal peptide sequence at the N
terminus, the presence ofa single putative N-glycosylation site
between Ml and P (a predicted extracellular stretch), and the
presence of two consensus protein kinase A phosphorylation
sites [(Lys/Arg)-(Lys/Arg)-Xaa-Xaa-(Ser/Thr); see ref. 35] in
the predicted cytoplasmic C-terminal portion of the channel
molecule (Fig. 1A) support the proposed folding. The putative
extracellular stretch following the Ml transmembrane region
displays a cell-adhesion sequence, Arg-Gly-Asp (RGD), that is
often involved in interaction with extracellular matrix proteins
such as integrins (36). At present, there are no data about the
involvement of KGA or other inward rectifier channels in
phenomena related to the extracellular matrix.
The homology between KGA and the two other members
of the family extends well into the C-terminal half of the
protein, up to Tyr-356, suggesting common function of this
(presumably cytoplasmic) domain in all three channels. Res-
idues in KGA that are C-terminal to Tyr-356 display little or
no homology to other known proteins; KGA is also 80 amino
acids longer than IRK1 and 111 amino acids longer than
ROMK1 (Fig. 1A). The first 42 amino acids of KGA also
display low homology to ROMK1 and IRK1. The unique N-
and C-terminal sequences ofKGA are candidates for involve-
ment in the control of gating by the a and/or 1y subunits of
G proteins.
Northern blot hybridization analysis ofRNA from various
rat tissues showed the presence of several RNA species
hybridizing to KGA cDNA of approximate sizes 2.3, 2.9, 3.9,
and 6.2kb in atrium and brain (Fig. 1C). In lung, RNA species
of 3.9, 2.9, 2.3, and 1.8 kb were observed. A single "3.8-kb
RNA band was found in skeletal muscle; no detectable KGA
RNA was found inXenopus oocytes (Fig. 1C); faint bands of
about 4 and 6.2 kb were seen in some preparations of
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FIG. 1. Structure and tissue distribution ofKGA. (A) Aligmnent of
the deduced primary structure of the KGA polypeptide with those of
IRK1 and ROMK1. Gaps were introduced in all sequences to improve
alignment. Dashes denote identical amino acid residues; asterisks
show the termination codons. Consensus protein kinase A phosphor-
ylation sites (gb), a consensus N-glycosylation site (#), and the
predicted transmembrane (Ml and M2) and pore (P) regions (dashed
lines) are shown in the KGA sequence. The proposed cytoplasmic
parts of the KGA polypeptide contain eight additional putative protein
kinase A sites with a lower probability of being phosphorylated
[(Lys/Arg)-Xaa-(Ser/Thr); ref. 35] and nine protein kinase C sites (not
shown). (B) Hydrophobicity plot of the KGA sequence. (C) Northern
blot hybridization analysis of poly(A)+ RNA from various tissues.
ventricle RNA (data not shown). It is unlikely that these
probes hybridized to IRK1 RNA, which shows a single band
of 5.5 kb in most tissues (18), or to ROMK1 RNA, which is
expressed mainly in kidney and spleen (17).
The various RNA species hybridizing to the KGA cDNA
may represent splice variants or isoforms ofKGA or homol-
ogous genes encoding inward-rectifier K+ channels. We have
screened a brain cDNA library and identified an -2.2-kb
cDNA that was identical to that of KGA except for an
additional stretch of 41 bp within the 5' untranslated region
(8 bp after its beginning; data not shown). This finding
suggests the presence in the brain ofaG protein-activated K+
channel, KGB1, with a primary amino acid sequence iden-
tical to that of KGA. The function of this protein as an
inwardly rectifying K+ channel was confirmed by expression
of KGB1 cRNA in oocytes coinjected with cRNA of either
5HT1A or 6-opioid receptor (data not shown).
The expressed KGA was activated by three receptor types
known to couple to Gi protein: 5HT1A, 8-opioid, and mus-
carinic m2 (Fig. 2). In each case, the inwardly rectifying K+
current could be activated when both KGA and the receptor
were heterologously expressed, but not when only the re-
ceptor or KGA cRNA was injected. The expressed receptors
displayed the expected pharmacological properties (37, 38):
5HT1A receptor response was elicited by 5HT concentration
as low as 1 nM and maximally at 80-100 nM and by a selective
5HT1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin
(data not shown); 8-opioid response was elicited by [Leu5l-
enkephalin and cyclic [2-(D-penicillamine),5-(D-penicilla-
mine)]enkephalin and inhibited by the selective &-opioid
antagonist naltrindole (Fig. 2B); and the m2 receptor re-
sponse was activated by acetylcholine (Fig. 2C) and blocked
by atropine (data not shown). These results suggest that the
KGA (and the identical KGB1) channel in the brain may
serve as effectors for a convergent action of many inhibitory
neurotransmitters.
In the atrium and in many other excitable cells, the
activation of G protein-activated inward-rectifier K+ chan-
nels is PTX-sensitive (1,2). InXenopus oocytes, the coupling
between the 5HT1A receptor and KGA channel activation
was mediated by an endogenous G protein as shown by
sensitivity to guanosine 5'-[13-thio]diphosphate (22); how-
ever, the identity of the endogenous G protein is not known,
and PTX treatment gave mixed results. We found that PTX
treatment (0.5-1 ug/ml, 24-36 hr) did not inhibit the activa-
tion of cloned KGA via the 6-opioid receptor in two batches
of oocytes and via the 5HT1A receptor in two offour batches.
For the two PTX-sensitive batches with 5HT1A, the treat-
ment reduced the 5HT1A response (I5HT) by 65% and 100o.
For the PTX-insensitive batches, coexpression of the a
subunit of Gi2 with KGA and 5HT1AR rendered the response
PTX-sensitive (>90% inhibition), in accord with the previous
findings with atrial poly(A)+ RNA-directed KGA (22). These
results confirm that the balance between PTX-sensitive and
PTX-insensitive G proteins in the oocytes is batch-dependent
(32) and demonstrate that KGA may be activated via G
proteins having either PTX-sensitive or PTX-insensitive a
subunits. This finding may be relevant to the evidence that f3y
subunits play a role in channel activation (13, 14, 39).
The electrophysiological properties of '5HT were further
characterized. The I-V characteristics of the whole cell
current in different external K+ concentrations showed
strong inward rectification and displayed gating dependent on
external K+ (Fig. 2D). The reversal potential of I5HT changed
by 56 mV per 10-fold change in K+ concentration (Fig. 2E),
Ten micrograms of each RNA was loaded on a 1% agarose gel.
Shorter exposures of the atrial RNA autoradiogram showed two
clearly resolved bands of larger molecular size, -3.9 and -6.2 kb.
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FIG. 2. Functional characterization ofKGA in whole oocytes by the two-electrode voltage-clamp technique. Holding potential was -80 mV.
(A-C) Inward currents evoked by the perfusion of the hK solution (see Materials and Methods for composition) (times of solution exchange
from ND96 to hK and back are shown on the horizontal line above the current traces), 80 nM 5HT (A), 20 nM cyclic [2-(D-penicillinamine),5-
(D-penicillinamine)]enkephalin (DP) (B), and 5 pM acetylcholine (ACh) (C). Note the block of DP response by 1 ,uM naltrindole (Nal) (B). (D)
I-Vrelations (averaged from two to three cells injected on the same day) ofthe 5HT1A receptor current response (ISHrr) in various concentrations
of K+. (E) Dependence of the reversal potential (Vrev) of ISHT on external K+ concentration. Each point represents mean t SEM of three to
seven determinations. (F) Ba2+ inhibition of the high-K+-induced current (IhK) (o) and I5HT (0). Each point represents mean t SEM of three
determinations.
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suggesting a high selectivity for K+ over Na+. I5HT was
blocked by 5-300 ,uM Ba2+, with 50% inhibition at 15 ,uM
(Fig. 2F). These features are indistinguishable from those of
KGA expressed in atrial poly(A)+ RNA-injected oocytes (22)
and similar to those in atrial cells (5, 6).
Changing the normal physiological solution (ND96) to the
hK solution was accompanied by the development of an
inward current (IhK; Fig. 2) reflecting basal activity ofinward-
rectifier K+ channels; in native oocytes, IhK ranged between
30 and 100 nA and was not inhibited by Ba2+ below 100 ,uM
(cf. ref. 22). In a representative oocyte batch, IhK was 37 ±
3 nA (n = 7) in native oocytes, 147 ± 15 nA (n = 7) in
KGA-expressing oocytes, and 122 ± 9 nA (n = 19) in oocytes
expressing both KGA and 5HT1A receptor. Similar results
were observed in >10 other oocyte batches. On many
occasions, especially with m2 and &-opioid receptors, IhK was
even higher when high doses of receptor RNA were used
(data not shown). The finding that KGA displays basal
activity with or without a coexpressed receptor supports the
suggestion that the basal activity of G protein-activated K+
channels contributes to the resting membrane conductance in
the absence of an activated receptor (5, 40, 41).
Single-channel recordings in cell-attached and inside-out
membrane patches revealed a strongly inwardly rectifying
channel in oocytes expressing the KGA channel plus the
5HT1A receptor (Fig. 3A) but not in native oocytes (data not
shown). The single-channel conductance in cell-attached
patches with 150 mM KCI in the pipette was 39.7 ± 1.3 pS (n
= 7), and in excised inside-out patches in symmetrical 150
mM KCI it was 39 ± 0.8 pS (n = 5) (Fig. 3B). This is similar
to 40-45 pS reported under similar conditions in newborn rat
atrial myocytes (42) and to what we have recorded in atrial
cells of adult rats (38.2 ± 3.2 pS, n = 4, in cell-attached
patches; 37.5 ± 5.5 pS, n = 2, in inside-out patches; Fig. 3B).
With 50-100 nM 5HT in the pipette, the activity of the
channel in most cell-attached patches was decreased within
several minutes (data not shown), possibly reflecting desen-
sitization also observed in whole-cell recordings (Fig. 2A)
and reported in the atrium (43, 44). After excision of the
patch, the activity of the channel ran down within a few
minutes (Fig. 3C), or even faster, but was restored, at least
partially, by the addition to the bath of 20-100 ,uM GTP[YS],
a nonhydrolyzable analog ofGTP (Fig. 3C; n = 9), as shown
previously in guinea pig and newborn rat atrial cells (e.g., ref.
42). Reactivation by GTP[yS] was also observed in adult rat
atrial cells (Fig. 3D). Activation of the expressed KGA
channel by a GTP analog in excised patches confirms the
membrane-delimited pathway of channel activation.
Cloning and expression ofKGA and KGB1 confirm that a
single protein can serve as an ion channel and a G-protein
effector. The existence of regions of sequence that are
homologous to those in G protein-independent inward-
rectifier K+ channels, and regions that are unique to KGA,
suggest that G protein-interaction and inward-rectification
functions reside in separate structural domains ofthe channel
polypeptide. Cloning of KGA may help to answer the out-
standing questions about the G protein-ion channel activa-
tion pathway, such as the nature of any complexes of the
receptor, G protein, and channel; the stoichiometry of the G
protein-channel interaction (45); the regulation by other
messenger systems; and the secondary and tertiary structure
of the K+ channel protein.
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